Literature DB >> 16880145

The evolving story of renal translocation carcinomas.

Pedram Argani, Marc Ladanyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16880145     DOI： 10.1309/EAEJTJGD5J4J3B4F

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  14 in total

1.  TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.

Authors:  Yongcan Xu; Qiu Rao; Qiuyuan Xia; Shanshan Shi; Qunli Shi; Henghui Ma; Zhenfeng Lu; Hui Chen; Xiaojun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.

Authors:  Chih-Jung Chen; Hui-Ting Hsu; Ming-Tsan Lin; Mariann Pintye; Jim-Ray Chen
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

3.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

4.  "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.

Authors:  Huiying He; Kiril Trpkov; Petr Martinek; Ozlem Tanas Isikci; Cristina Maggi-Galuzzi; Reza Alaghehbandan; Anthony J Gill; Maria Tretiakova; Jose Ignacio Lopez; Sean R Williamson; Delia Perez Montiel; Maris Sperga; Eva Comperat; Fadi Brimo; Ali Yilmaz; Kristyna Pivovarcikova; Kveta Michalova; David Slouka; Kristyna Prochazkova; Milan Hora; Michael Bonert; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2018-09-19       Impact factor: 4.064

Review 5.  MiT family translocation renal cell carcinomas: A 15th anniversary update.

Authors:  Jatin S Gandhi; Faizan Malik; Mahul B Amin; Pedram Argani; Armita Bahrami
Journal:  Histol Histopathol       Date:  2019-09-06       Impact factor: 2.303

6.  Cardiopulmonary bypass-assisted surgery for the treatment of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a tumor thrombus within the inferior vena cava: A case report.

Authors:  Guanchen Zhu; Xuefeng Qiu; Xianchen Chen; Guangxiang Liu; Gutian Zhang; Weidong Gan; Hongqian Guo
Journal:  Oncol Lett       Date:  2015-09-24       Impact factor: 2.967

Review 7.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

8.  [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

9.  Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.

Authors:  Henry B Armah; Anil V Parwani; Urvashi Surti; Sheldon I Bastacky
Journal:  Diagn Pathol       Date:  2009-05-18       Impact factor: 2.644

10.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.